Autism Spectrum Disorder Trial, Recruiting (NCT06622395)

Autism Spectrum Disorder Trial, Recruiting NCT06622395 Sponsor: Centre Hospitalier St Anne Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06622395 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children between 24 months and 5 years old whose families have requested a diagnostic assessment at the Autism and Related Disorders Research and Diagnostic Center (CREDAT).
Families who agree to take part in the research alongside their child's already-planned assessment at CREDAT, including following the consent process required for children.
Families who understand French well enough to complete two specific assessment tools used in the study (a parent interview and an observation session).

Who may not be able to join:

Families who do not have access to adequate technology needed to take part in video appointments (teleconsultation).
Families who do not wish to take part in the research.
Children who have a confirmed hearing or vision difficulty that is not being managed with aids such as glasses or hearing aids.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0145654124

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06622395

Sponsor: Centre Hospitalier St Anne

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: 0145654124

More information: https://clinicaltrials.gov/study/NCT06622395

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children between 24 months and 5 years old whose families have requested a diagnostic assessment at the Autism and Related Disorders Research and Diagnostic Center (CREDAT).
Families who agree to take part in the research alongside their child's already-planned assessment at CREDAT, including following the consent process required for children.
Families who understand French well enough to complete two specific assessment tools used in the study (a parent interview and an observation session).

Who may not be able to join:

Families who do not have access to adequate technology needed to take part in video appointments (teleconsultation).
Families who do not wish to take part in the research.
Children who have a confirmed hearing or vision difficulty that is not being managed with aids such as glasses or hearing aids.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Hospitalier St Anne

Registry

ClinicalTrials.gov

Start date

29 April 2022

Est. completion

30 April 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Evaluation of the Validity of Remote Diagnosis for Autism Spectrum Disorder in Children Aged 24 to 60 Months with Neurodevelopmental Disorders. First Test (Remote): Visit 1 - Autism Diagnostic Interview-Revised (ADI-R); Evaluation of the Validity of Remote Diagnosis for Autism Spectrum Disorder in Children Aged 24 to 60 Months with Neurodevelopmental Disorders. Second Test (Remote): Visit 2 - Brief Observation of Symptoms of Autism (BOSA); Standard diagnostic pathway (as usual), with the first visit conducted in person: First Test (in person): Visit 0 - Autism Diagnostic Interview-Revised (ADI...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov